atai Life Sciences - Phase 1 trial of kratom-derived pharmaceutical
atai and Kures are poised to address two key factors underlying the opioid epidemic developing a potentially safer and more widely available
atai and Kures are poised to address two key factors underlying the opioid epidemic developing a potentially safer and more widely available